Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
ANRO
Stock Latest News
Ratings
Alto Neuroscience, Inc.: Promising Clinical Trials and Strong Financial Position Justify Buy Rating
5d ago
ANRO
Premium
Company Announcements
Alto Neuroscience Advances Precision Psychiatry Pipeline
7d ago
ANRO
Premium
Ratings
Alto Neuroscience, Inc.: Buy Rating Affirmed on Strong Financial Outlook and Promising Clinical Trials
8d ago
ANRO
Premium
Ratings
Promising Future for Alto Neuroscience: Strong Pipeline and Financial Stability Drive Buy Rating
8d ago
ANRO
Premium
Company Announcements
Alto Neuroscience Approves Key Proposals at Annual Meeting
9d ago
8K
ANRO
Premium
Ratings
Optimistic Outlook on Alto Neuroscience: Advancements in Precision Neuropsychiatry and Biomarker-Driven Treatments
22d ago
ANRO
Premium
Ratings
Innovative Biomarker-Driven Strategy and Promising Pipeline Support Buy Rating for Alto Neuroscience
23d ago
ANRO
Premium
The Fly
Alto Neuroscience presents new data at Society of Biological Psychiatry meeting
25d ago
ANRO
Premium
The Fly
Alto Neuroscience initiated with a Buy at H.C. Wainwright
2M ago
ANRO
Premium
Ratings
Buy Rating Reaffirmed for Alto Neuroscience, Inc. Amid Promising Pipeline and Upcoming Data Readouts
2M ago
ANRO
Premium
Ratings
Promising Clinical Trials and Strong Financials Justify Buy Rating for Alto Neuroscience, Inc.
2M ago
ANRO
Premium
Company Announcements
Alto Neuroscience Advances Clinical Trials with Strong Financials
2M ago
ANRO
Premium
Company Announcements
Alto Neuroscience Announces Board Member Departures
2M ago
8K
ANRO
Premium
Pre-Earnings
Alto Neuroscience, Inc. (ANRO) Q4 Earnings Cheat Sheet
2M ago
ANRO
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
ALDX
ANRO
Premium
The Fly
Alto Neuroscience rises 19.6%
3M ago
ANRO
Premium
The Fly
Alto Neuroscience rises 25.0%
3M ago
ANRO
Premium
Stock Analysis & Ideas
Jefferies Predicts Up to ~500% Jump for These 2 ‘Strong Buy’ Stocks
3M ago
TIL
ANRO
Premium
The Fly
USPTO grants Alto Neuroscience patent for MDD treatment covering ALTO-300
3M ago
ANRO
Premium
Ratings
Promising Outlook for Alto Neuroscience with ALTO-300’s Phase IIb Success Reinforcing Buy Rating
3M ago
ANRO
Premium
The Fly
Alto Neuroscience announces interim analysis from ALTO-300 trial
3M ago
ANRO
Premium
The Fly
Alto Neuroscience files $300M mixed securities shelf
4M ago
ANRO
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
